Injectable peptides are not licensed for human use, and injecting carries a particular hazard
Ensuring adequate hydration is therefore an important consideration with GLP-1 RA treatment, as is recommended by the label, particularly for people with renal impairment, as dehydration is known to be associated with renal dysfunction [98]
Moreover, the faster metabolic rate of short-acting GLP-1RAs may induce abrupt changes in gastrointestinal function, further supporting the higher incidence of nausea and vomiting with these agents
Aron-Wisnewsky, J., Warmbrunn, M
This article provides a clear, practical blueprint to help clinic leaders streamline their GLP1 clinic workflow , optimize staffing models, and implement sustainable patient education strategies
Doctors usually decide based on your symptoms, health history, lab work, treatment goals and how your body may respond to each option